Mark Newcomer Sells 40,000 Shares of Paysign, Inc. (NASDAQ:PAYS) Stock

Posted by Frank Smitson on Nov 23rd, 2024

Paysign, Inc. (NASDAQ:PAYS – Get Free Report) CEO Mark Newcomer sold 40,000 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $3.24, for a total value of $129,600.00. Following the completion of the transaction, the chief executive officer now directly owns 9,296,886 shares in the company, valued at $30,121,910.64. This represents a 0.43 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Mark Newcomer also recently made the following trade(s):

On Wednesday, November 20th, Mark Newcomer sold 25,000 shares of Paysign stock. The shares were sold at an average price of $3.27, for a total value of $81,750.00.
On Wednesday, October 23rd, Mark Newcomer sold 36,000 shares of Paysign stock. The stock was sold at an average price of $3.66, for a total transaction of $131,760.00.
On Monday, October 21st, Mark Newcomer sold 22,000 shares of Paysign stock. The stock was sold at an average price of $3.75, for a total transaction of $82,500.00.
On Monday, September 23rd, Mark Newcomer sold 50,000 shares of Paysign stock. The stock was sold at an average price of $4.25, for a total transaction of $212,500.00.
On Thursday, September 19th, Mark Newcomer sold 1,500 shares of Paysign stock. The stock was sold at an average price of $4.50, for a total transaction of $6,750.00.
On Friday, September 13th, Mark Newcomer sold 1,500 shares of Paysign stock. The stock was sold at an average price of $4.50, for a total transaction of $6,750.00.

Paysign Stock Up 0.6 %

Paysign stock opened at $3.46 on Friday. The company’s fifty day simple moving average is $3.83 and its 200-day simple moving average is $4.29. Paysign, Inc. has a 12 month low of $2.22 and a 12 month high of $5.59. The stock has a market cap of $185.28 million, a P/E ratio of 23.07 and a beta of 0.95.

Paysign (NASDAQ:PAYS – Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of $0.01 by $0.02. Paysign had a net margin of 14.28% and a return on equity of 30.64%. The business had revenue of $15.26 million for the quarter, compared to analysts’ expectations of $14.96 million. During the same period in the previous year, the company posted $0.02 EPS. On average, equities research analysts expect that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Barrington Research reiterated an “outperform” rating and set a $7.00 price objective on shares of Paysign in a research report on Monday, November 4th.

Check Out Our Latest Report on PAYS

Hedge Funds Weigh In On Paysign

Several institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in shares of Paysign by 3.0% during the 1st quarter. Vanguard Group Inc. now owns 1,649,043 shares of the company’s stock valued at $6,035,000 after acquiring an additional 48,489 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Paysign by 25.0% in the second quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company’s stock worth $6,484,000 after purchasing an additional 301,000 shares in the last quarter. Joule Financial LLC bought a new stake in Paysign in the third quarter worth $1,478,000. Royce & Associates LP bought a new stake in Paysign in the third quarter worth $814,000. Finally, GSA Capital Partners LLP boosted its holdings in Paysign by 31.2% in the third quarter. GSA Capital Partners LLP now owns 117,028 shares of the company’s stock worth $429,000 after purchasing an additional 27,829 shares in the last quarter. 25.89% of the stock is currently owned by hedge funds and other institutional investors.

About Paysign

(Get Free Report)

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.